Abstract
Study design:
Prospective, open-label, comparative study, to assess the effects of sildenafil on blood pressure in a population of patients with spinal cord injury (SCI).
Objectives:
To determine the effect of sildenafil on blood pressure in patients with erectile dysfunction secondary to SCI by comparing changes in blood pressure in SCI patients with a neurologic level below T5 versus higher levels. To establish a relationship between the potential hypotensive effect and protective muscle spasm against blood pressure reduction. To assess the effects of age, complexity and duration of SCI on changes in blood pressure. To record any adverse effects occurring during the study.
Setting:
Spinal Cord Injury Unit, Insular University Hospital of Gran Canaria, Canary Islands, Spain.
Subjects:
In total, 22 male SCI patients aged 18 years or older with a history of SCI greater than 3 months in duration.
Methods:
Patients with erectile dysfunction secondary to SCI were induded in the study, without excluding patients with a neurologic level above 75 or asymptomatic low blood pressure. Patients with specific contraindications for use of the drug were excluded. A personal history was obtained, and the level of injury (ASIA/IMSOP scales of international standards), impairment grade (ASIA impairment scale), spasticity grade (modified Ashworth scale) and baseline sitting and supine blood pressure values were determined. A single dose of 50 mg of sildenafil was administered, and patients remained sitting at 45°. Blood pressure was monitored every 10 min for 4 h and whenever the patient reported symptoms. Any relevant signs and symptoms manifested during the study period were also recorded. Analysis of the changes in blood pressure values was performed using a paired t-test in each group of patients according to neurologic level and spasticity grade.
Results:
A decrease in blood pressure was observed in all patients, although patients with a level of injury at T5 or above and those with a complete SCI showed a less intense decrease (P<0.05). The spasticity grade of the patients was protective against the fall in blood pressure, as it was less significant in patients with grade 3 (P>0.1) than in those with grade 0. Adverse effects were few and transient. None were related to hypotension.
Conclusion:
Sildenafil caused a decrease in blood pressure in SCI patients with a neurologic level of injury above T5 and complete injuries (grade A), but did not have clinical implications in the patients studied. A higher spasticity grade tends to protect the patient from the fall in blood pressure. Age and duration of injury do not appear to influence this decrease.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
NIH Consensus Development Panel on Impotence. Impotence. JAMA 1993; 270: 83–90.
Sánchez Ramos A et al. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord 2001; 39: 637–643.
Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl Med 1998; 338: 1397–1404.
Morales A et al. Clinical safety of oral sildenafil citrate (Viagra®) in the treatment of erectile dysfunction. Int J Impot Res 1998; 10: 69–74.
Padma-Nathan H et al. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract 1998; 52: 375–379.
Derry FA et al. Efficacy and safety of oral sildenafil (Viagra®) in men with erectile dysfunction caused by spinal cord injury. Neurology 1998; 51: 1629–1633.
Maytom MC et al. A two-part pilot study of sildenafilo (Viagra®) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 1999; 37: 110–116.
Guliano F et al. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Ann Neurol 1999; 46: 15–21.
Andersson KE, Wagner G . Physiology of penile erection. Biol Reprod 1995; 75: 191–236.
Burnett AL . The role of nitric oxide in the physiology of erection. Biol Reprod 1995; 52: 485–489.
Boolell M et al. Sildenafil. An oral active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47–52.
Arcoraci C, Orellano S, Discepolo M, Ribs R . Tratamiento de la disfuncion erectil sexual con sildenafilo en pacientes con hemodialisis e interaccion con las drogas hipertensivas. Rev Nefrol Dial y Transpl 2000; 50: 29–31.
Gans WH et al. Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury. J Spinal Cord Med 2001; 24: 35–40.
Rosen RC et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
Schmid DIVI, Schurch B, Hauri D . Sildenafil in the treatment of sexual dysfunction in spinal cord-injuried male patients. Eur Urol 2000; 38: 184–193.
Derry F, Hultling C, Seftel AD, Sipski ML . Efficacy and safety of sildenafil citrate (Viagra®) in men with erectile dysfunction and spinal cord injury: a review. Urology 2002; 60(suppl): 49–57.
Maynard FM, Karunas R, Waring WW . Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil 1990; 71: 566–569.
Levi R, Hulting C, Seiger A . The Stockholm Spinal Cord Injury Study: 2. Associations between clinical patient characteristics and post-acute medical problems. Paraplegia 1995; 33: 585–594.
Ignarro LJ et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739–749.
Lugnier C, Komas N . Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. Eur Heart 3 1993; 14(suppl 1): 141–148.
Bohannon RW, Mellissa BS . Interater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1985; 65: 46–47.
DeVivo M . Epidemiology of traumatic spinal cord injury. In: Kirshblum S, Campagnolo DI, DeLisa JA (eds). Spinal Cord Medicine. Lippincott Williams and Wilkins: Philadelphia 2002, pp 69–81.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
García-Bravo, A., Suárez-Hernández, D., Ruiz-Fernández, M. et al. Determination of changes in blood pressure during administration of sildenafil (Viagra®) in patients with spinal cord injury and erectile dysfunction. Spinal Cord 44, 301–308 (2006). https://doi.org/10.1038/sj.sc.3101846
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.sc.3101846
Keywords
This article is cited by
-
Influence of the neurological level of spinal cord injury on cardiovascular outcomes in humans: a meta-analysis
Spinal Cord (2012)
-
Treatment of erectile dysfunction following spinal cord injury
Current Urology Reports (2009)
-
Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men
Spinal Cord (2007)
-
Long-term effects of spinal cord injury on sexual function in men: implications for neuroplasticity
Spinal Cord (2007)
